Assessing the Impact of the Absence of Detrusor Muscle in Ta Low-grade Urothelial Carcinoma of the Bladder on Recurrence-free Survival

被引:19
|
作者
Mastroianni, Riccardo [1 ,2 ]
Brassetti, Ado [1 ]
Krajewski, Wojciech [3 ]
Zdrojowy, Romuald [3 ]
Al Salhi, Yazan [4 ]
Anceschi, Umberto [1 ]
Bove, Alfredo Maria [1 ]
Carbone, Antonio [4 ]
De Nunzio, Cosimo [5 ]
Fuschi, Andrea [4 ]
Ferriero, Mariaconsiglia [1 ]
Nacchia, Antonio [5 ]
Pastore, Antonio Luigi [4 ]
Tema, Giorgia [5 ]
Tuderti, Gabriele [1 ]
Gallucci, Michele [2 ]
Simone, Giuseppe [1 ]
机构
[1] Regina Elena Inst Canc Res, Dept Urol, Via Elio Chianesi 53, I-00154 Rome, RM, Italy
[2] Sapienza Univ, Dept Urol, Rome, Italy
[3] Wroclaw Med Univ, Dept Urol & Urol Oncol, Wroclaw, Poland
[4] Sapienza Univ ICOT, Dept Medico Surg Sci & Biotechnol, Urol Unit, Latina, Italy
[5] St Andrea Hosp, Dept Urol, Rome, Italy
来源
EUROPEAN UROLOGY FOCUS | 2021年 / 7卷 / 06期
关键词
Non-muscle-invasive bladder cancer; Detrusor muscle; Transurethral resection of the bladder; Recurrence-free survival; Low-risk bladder cancer; Intermediate-risk bladder cancer; Low-grade bladder cancer; TRANSURETHRAL RESECTION; EUROPEAN ORGANIZATION; INDIVIDUAL PATIENTS; PROGNOSTIC-FACTORS; STAGE TA; CANCER; RISK; CLASSIFICATION; PROGRESSION; NEOPLASMS;
D O I
10.1016/j.euf.2020.08.007
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Obtaining detrusor muscle (DM) in transurethral resection of bladder tumor (TURBt) specimen is considered a surrogate marker of resection quality. However, evidence was principally investigated in high-risk tumors. Therefore, DM sampling for low-grade (LG) urothelial carcinoma (UC) remains poorly investigated and certainly requires further investigation. Objective: To assess whether the absence of DM in TURBt specimen has a negative impact on recurrence-free survival (RFS) in patients with a Ta LG UC. Design, setting, and participants: A multicenter TURBt database was queried for "LG, Ta, UC of the bladder." All patients treated between 1996 and 2018 with tumor grade assessed according to both 1973 World Health Organization and 2004 WHO/International Society of Urological Pathology grading classifications and with a minimum follow-up of 1 yr were included. Patients with a previous history of high-grade UC, upper urinary tract UC, or bladder tumor differentiations other than UC were excluded. Intervention: TURBt. Outcome measurements and statistical analysis: Baseline demographic, clinical, and pathologic data were analyzed. The European Organization for Research and Treatment of Cancer (EORTC) risk group was recorded. Kaplan-Meier analysis was performed to assess the predictive role of clinical and pathologic data for RFS. Univariable and multivariable Cox regression analyses were performed to identify the predictors of recurrence. Results and limitations: Overall, 521 patients were included. At Kaplan-Meier analysis, the low-risk cohort displayed significantly higher RFS than the intermediate-risk cohort (1-yr RFS 87% vs 79%; log-rank p = 0.007). At univariable Cox regression analysis, only gender, multiple tumors, tumor diameter >= 3 cm, and EORTC risk group were significant predictors of recurrence. Absence of DM had no impact on RFS. Multivariable Cox regression analysis confirmed gender and EORTC risk group as independent predictors of recurrence. Conclusions: Absence of DM in TURBt specimen has negligible role in RFS of patients with Ta LG tumors of the bladder. Patient summary: In this study, we assessed the role that detrusor muscle (DM) in transurethral resection of bladder tumor specimen has in recurrence-free survival, in patients with a Ta low-grade urothelial carcinoma of the bladder. Absence of DM has no impact on tumor recurrence; therefore, it does not require additional attention. (C) 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1324 / 1331
页数:8
相关论文
共 50 条
  • [21] Does Bladder Outlet Obstruction Releated to Recurrence In Low Risk Ta Low Grade Non Muscle Invasive Bladder Cancer?
    Yentur, Serhat
    Dusunus, Yunus Emre
    Ulus, Ismail
    Kandirali, Ismail Engin
    Sahin, Sergen
    CLINICAL GENITOURINARY CANCER, 2025, 23 (02)
  • [22] Preoperative prognostic nutritional index and nomogram predicting recurrence-free survival in patients with primary non-muscle-invasive bladder cancer without carcinoma in situ
    Cui, Jianfeng
    Chen, Shouzhen
    Bo, Qiyu
    Wang, Shiyu
    Zhang, Ning
    Yu, Meng
    Wang, Wenfu
    Han, Jie
    Zhu, Yaofeng
    Shi, Benkang
    ONCOTARGETS AND THERAPY, 2017, 10 : 5541 - 5550
  • [23] Development and external validation of a novel nomogram model for predicting postoperative recurrence-free survival in non-muscle-invasive bladder cancer
    Ding, Li
    Deng, Xiaobin
    Xia, Wentao
    Wang, Kun
    Zhang, Yang
    Zhang, Yan
    Shao, Xianfeng
    Wang, Junqi
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [24] Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection
    Espiritu, Patrick N.
    Sverrisson, Einar F.
    Sexton, Wade J.
    Pow-Sang, Julio M.
    Poch, Michael A.
    Dhillon, Jasreman
    Spiess, Philippe E.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (05) : 619 - 624
  • [25] Surgical checklist impact on recurrence-free survival of patients with non-muscle-invasive bladder cancer undergoing transurethral resection of bladder tumour
    Suarez-Ibarrola, Rodrigo
    Soria, Francesco
    Abufaraj, Mohammad
    D'Andrea, David
    Preto, Mirko
    Gust, Kilian M.
    Briganti, Alberto
    Shariat, Shahrokh F.
    Gontero, Paolo
    BJU INTERNATIONAL, 2019, 123 (04) : 646 - 650
  • [26] The Clinical Impact of Tumor Grade Heterogeneity in Non- muscle-invasive Urothelial Carcinoma of the Bladder
    Culpan, Meftun
    Keser, Ferhat
    Iplikci, Ayberk
    Kir, Gozde
    Atis, Gokhan
    Yildirim, Asif
    MEDENIYET MEDICAL JOURNAL, 2021, 36 (04): : 310 - 317
  • [27] Recurrent Ta Low-grade Non-muscle-invasive Bladder Cancer: What Are the Options?
    Roupret, Morgan
    Malmstrom, Per-Uno
    Black, Peter
    EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (06): : 723 - 729
  • [28] Immediate intravesical chemotherapy for low-grade bladder tumors in California: An underutilized practice and its impact on recurrence
    Yap, Stanley A.
    Brunson, Ann
    Pugashetti, Neil
    Cress, Rosemary D.
    Keegan, Theresa H. M.
    White, Ralph de Vere
    Wun, Ted
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (11) : 498.e1 - 498.e7
  • [29] Cytopathologic differential diagnosis of low-grade urothelial carcinoma and reactive urothelial proliferation in bladder washings: a logistic regression analysis
    Cakir, Ebru
    Kucuk, Ulku
    Pala, Emel Ebru
    Sezer, Ozlem
    Ekin, Rahmi Gokhan
    Cakmak, Ozgur
    APMIS, 2017, 125 (05) : 431 - 436
  • [30] Does Ta Low-grade Urothelial Carcinoma of the Bladder With Focal High-grade Features Carry Worse Prognosis? The Roswell Park Comprehensive Cancer Center Experience
    Abou Heidar, Nassib
    Mahmood, Abdul Wasay
    Khan, Mohammad
    Harrington, Grace
    Ahmad, Ali
    Abdelhaq, Dawod
    Colan, Nicholas
    Whitt, Jor'Dan
    Sullivan, Daniel
    Howlader, Muhsinah
    Plecas, Zachary
    Ahmed, Zaineb
    Jing, Zhe
    Li, Qiang
    Guru, Khurshid A.
    Hussein, Ahmed A.
    UROLOGY, 2024, 193 : 136 - 142